annual D&A:
$207.20M+$37.70M(+22.24%)Summary
- As of today (August 17, 2025), VRTX annual depreciation & amortization is $207.20 million, with the most recent change of +$37.70 million (+22.24%) on December 31, 2024.
- During the last 3 years, VRTX annual D&A has risen by +$81.60 million (+64.97%).
- VRTX annual D&A is now at all-time high.
Performance
VRTX Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$51.70M+$3.30M(+6.82%)Summary
- As of today (August 17, 2025), VRTX quarterly depreciation & amortization is $51.70 million, with the most recent change of +$3.30 million (+6.82%) on June 30, 2025.
- Over the past year, VRTX quarterly D&A has dropped by -$2.30 million (-4.26%).
- VRTX quarterly D&A is now -4.26% below its all-time high of $54.00 million, reached on June 30, 2024.
Performance
VRTX quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$199.80M-$2.30M(-1.14%)Summary
- As of today (August 17, 2025), VRTX TTM depreciation & amortization is $199.80 million, with the most recent change of -$2.30 million (-1.14%) on June 30, 2025.
- Over the past year, VRTX TTM D&A has increased by +$3.00 million (+1.52%).
- VRTX TTM D&A is now -3.90% below its all-time high of $207.90 million, reached on September 30, 2024.
Performance
VRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
VRTX Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.2% | -4.3% | +1.5% |
| 3 y3 years | +65.0% | +38.6% | +44.0% |
| 5 y5 years | +93.8% | +93.7% | +89.2% |
VRTX Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +65.0% | -4.3% | +40.9% | -3.9% | +44.0% |
| 5 y | 5-year | at high | +93.8% | -4.3% | +94.0% | -3.9% | +89.2% |
| alltime | all time | at high | >+9999.0% | -4.3% | +8516.7% | -3.9% | >+9999.0% |
VRTX Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $51.70M(+6.8%) | $199.80M(-1.1%) |
| Mar 2025 | - | $48.40M(+4.1%) | $202.10M(-2.5%) |
| Dec 2024 | $207.20M(+22.2%) | $46.50M(-12.6%) | $207.20M(-0.3%) |
| Sep 2024 | - | $53.20M(-1.5%) | $207.90M(+5.6%) |
| Jun 2024 | - | $54.00M(+0.9%) | $196.80M(+6.8%) |
| Mar 2024 | - | $53.50M(+13.3%) | $184.20M(+8.7%) |
| Dec 2023 | $169.50M(+14.3%) | $47.20M(+12.1%) | $169.50M(+5.5%) |
| Sep 2023 | - | $42.10M(+1.7%) | $160.70M(+3.5%) |
| Jun 2023 | - | $41.40M(+6.7%) | $155.30M(+2.7%) |
| Mar 2023 | - | $38.80M(+1.0%) | $151.20M(+2.0%) |
| Dec 2022 | $148.30M(+18.1%) | $38.40M(+4.6%) | $148.30M(+3.2%) |
| Sep 2022 | - | $36.70M(-1.6%) | $143.73M(+3.6%) |
| Jun 2022 | - | $37.30M(+3.9%) | $138.73M(+4.6%) |
| Mar 2022 | - | $35.90M(+6.1%) | $132.67M(+5.6%) |
| Dec 2021 | $125.60M(+14.7%) | $33.83M(+6.7%) | $125.60M(+3.7%) |
| Sep 2021 | - | $31.70M(+1.5%) | $121.12M(+4.4%) |
| Jun 2021 | - | $31.24M(+8.3%) | $116.07M(+4.1%) |
| Mar 2021 | - | $28.83M(-1.8%) | $111.53M(+1.8%) |
| Dec 2020 | $109.52M(+2.4%) | $29.36M(+10.2%) | $109.52M(+2.9%) |
| Sep 2020 | - | $26.64M(-0.2%) | $106.42M(+0.8%) |
| Jun 2020 | - | $26.70M(-0.5%) | $105.62M(-0.9%) |
| Mar 2020 | - | $26.82M(+2.2%) | $106.62M(-0.3%) |
| Dec 2019 | $106.94M(+47.7%) | $26.26M(+1.6%) | $106.94M(+7.5%) |
| Sep 2019 | - | $25.85M(-6.7%) | $99.51M(+7.2%) |
| Jun 2019 | - | $27.70M(+2.1%) | $92.86M(+11.6%) |
| Mar 2019 | - | $27.14M(+44.2%) | $83.22M(+14.9%) |
| Dec 2018 | $72.42M(+18.0%) | $18.83M(-1.9%) | $72.42M(+3.4%) |
| Sep 2018 | - | $19.19M(+6.3%) | $70.03M(+6.0%) |
| Jun 2018 | - | $18.06M(+10.5%) | $66.06M(+5.0%) |
| Mar 2018 | - | $16.34M(-0.5%) | $62.89M(+2.4%) |
| Dec 2017 | $61.40M(-0.0%) | $16.43M(+7.9%) | $61.40M(+1.6%) |
| Sep 2017 | - | $15.22M(+2.2%) | $60.42M(+1.1%) |
| Jun 2017 | - | $14.89M(+0.3%) | $59.76M(-0.1%) |
| Mar 2017 | - | $14.85M(-3.9%) | $59.83M(-2.5%) |
| Dec 2016 | $61.40M(-1.5%) | $15.45M(+6.1%) | $61.40M(-0.5%) |
| Sep 2016 | - | $14.57M(-2.6%) | $61.69M(-2.5%) |
| Jun 2016 | - | $14.96M(-8.8%) | $63.29M(+1.4%) |
| Mar 2016 | - | $16.41M(+4.2%) | $62.40M(+0.1%) |
| Dec 2015 | $62.34M(-1.4%) | $15.75M(-2.6%) | $62.34M(-0.9%) |
| Sep 2015 | - | $16.17M(+15.0%) | $62.93M(-1.2%) |
| Jun 2015 | - | $14.06M(-14.0%) | $63.73M(-0.2%) |
| Mar 2015 | - | $16.36M(+0.2%) | $63.83M(+0.9%) |
| Dec 2014 | $63.26M(+30.8%) | $16.34M(-3.7%) | $63.26M(-2.0%) |
| Sep 2014 | - | $16.96M(+19.7%) | $64.55M(+13.1%) |
| Jun 2014 | - | $14.17M(-10.2%) | $57.08M(+6.8%) |
| Mar 2014 | - | $15.79M(-10.5%) | $53.46M(+10.5%) |
| Dec 2013 | $48.37M(+26.6%) | $17.63M(+85.8%) | $48.37M(+12.2%) |
| Sep 2013 | - | $9.49M(-10.1%) | $43.11M(+2.1%) |
| Jun 2013 | - | $10.55M(-1.3%) | $42.21M(+4.7%) |
| Mar 2013 | - | $10.69M(-13.6%) | $40.32M(+5.6%) |
| Dec 2012 | $38.19M(+9.0%) | $12.37M(+44.0%) | $38.19M(+7.5%) |
| Sep 2012 | - | $8.59M(-0.8%) | $35.54M(+2.4%) |
| Jun 2012 | - | $8.66M(+1.2%) | $34.70M(-0.1%) |
| Mar 2012 | - | $8.56M(-12.0%) | $34.74M(-0.9%) |
| Dec 2011 | $35.04M(+15.0%) | $9.72M(+25.5%) | $35.04M(+4.5%) |
| Sep 2011 | - | $7.75M(-11.0%) | $33.52M(+3.0%) |
| Jun 2011 | - | $8.71M(-1.7%) | $32.53M(+2.5%) |
| Mar 2011 | - | $8.86M(+8.0%) | $31.73M(+4.2%) |
| Dec 2010 | $30.46M(+1.2%) | $8.21M(+21.4%) | $30.46M(-0.6%) |
| Sep 2010 | - | $6.76M(-14.6%) | $30.64M(-0.2%) |
| Jun 2010 | - | $7.91M(+4.3%) | $30.69M(+0.5%) |
| Mar 2010 | - | $7.58M(-9.5%) | $30.53M(+1.4%) |
| Dec 2009 | $30.11M(-6.5%) | $8.38M(+23.0%) | $30.11M(-0.6%) |
| Sep 2009 | - | $6.82M(-12.0%) | $30.30M(-3.6%) |
| Jun 2009 | - | $7.75M(+8.1%) | $31.44M(-1.3%) |
| Mar 2009 | - | $7.16M(-16.5%) | $31.86M(-1.0%) |
| Dec 2008 | $32.20M | $8.57M(+7.8%) | $32.20M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2008 | - | $7.95M(-2.7%) | $31.07M(+3.7%) |
| Jun 2008 | - | $8.17M(+9.0%) | $29.95M(+4.6%) |
| Mar 2008 | - | $7.50M(+0.6%) | $28.64M(+4.3%) |
| Dec 2007 | $27.46M(+6.2%) | $7.45M(+9.0%) | $27.46M(+2.1%) |
| Sep 2007 | - | $6.83M(-0.2%) | $26.88M(+3.5%) |
| Jun 2007 | - | $6.85M(+8.4%) | $25.98M(+0.2%) |
| Mar 2007 | - | $6.32M(-8.1%) | $25.94M(+0.3%) |
| Dec 2006 | $25.87M(-5.2%) | $6.88M(+15.9%) | $25.87M(-0.1%) |
| Sep 2006 | - | $5.93M(-12.9%) | $25.88M(-4.1%) |
| Jun 2006 | - | $6.81M(+8.9%) | $26.98M(+1.0%) |
| Mar 2006 | - | $6.25M(-9.3%) | $26.70M(-2.2%) |
| Dec 2005 | $27.29M(-7.9%) | $6.89M(-2.0%) | $27.29M(-4.0%) |
| Sep 2005 | - | $7.03M(+7.6%) | $28.42M(-0.6%) |
| Jun 2005 | - | $6.53M(-4.5%) | $28.60M(-2.6%) |
| Mar 2005 | - | $6.84M(-14.7%) | $29.36M(-1.0%) |
| Dec 2004 | $29.64M(+26.5%) | $8.02M(+11.3%) | $29.64M(+8.0%) |
| Sep 2004 | - | $7.21M(-1.0%) | $27.44M(+18.6%) |
| Jun 2004 | - | $7.28M(+2.2%) | $23.14M(-0.8%) |
| Mar 2004 | - | $7.13M(+22.4%) | $23.31M(-0.5%) |
| Dec 2003 | $23.44M(-7.8%) | $5.82M(+100.3%) | $23.44M(-5.9%) |
| Sep 2003 | - | $2.91M(-61.1%) | $24.91M(-12.8%) |
| Jun 2003 | - | $7.46M(+2.9%) | $28.58M(+4.3%) |
| Mar 2003 | - | $7.25M(-0.7%) | $27.40M(+7.7%) |
| Dec 2002 | $25.43M(+41.6%) | $7.30M(+11.0%) | $25.43M(+6.6%) |
| Sep 2002 | - | $6.57M(+4.6%) | $23.86M(-0.4%) |
| Jun 2002 | - | $6.28M(+18.9%) | $23.95M(+15.5%) |
| Mar 2002 | - | $5.28M(-7.7%) | $20.73M(+15.4%) |
| Dec 2001 | $17.96M(+97.5%) | $5.72M(-14.0%) | $17.96M(+20.0%) |
| Sep 2001 | - | $6.66M(+116.9%) | $14.97M(+41.0%) |
| Jun 2001 | - | $3.07M(+22.1%) | $10.62M(+9.6%) |
| Mar 2001 | - | $2.51M(-8.1%) | $9.68M(+6.5%) |
| Dec 2000 | $9.10M(+46.6%) | $2.73M(+18.9%) | $9.10M(+10.6%) |
| Sep 2000 | - | $2.30M(+7.8%) | $8.22M(+8.0%) |
| Jun 2000 | - | $2.13M(+11.0%) | $7.62M(+10.6%) |
| Mar 2000 | - | $1.92M(+3.3%) | $6.89M(+11.0%) |
| Dec 1999 | $6.21M(+37.3%) | $1.86M(+10.0%) | $6.21M(+8.0%) |
| Sep 1999 | - | $1.69M(+20.6%) | $5.75M(+10.6%) |
| Jun 1999 | - | $1.41M(+12.9%) | $5.19M(+7.5%) |
| Mar 1999 | - | $1.24M(-11.4%) | $4.83M(+6.9%) |
| Dec 1998 | $4.52M(+26.0%) | $1.40M(+23.0%) | $4.52M(+9.8%) |
| Sep 1998 | - | $1.14M(+9.4%) | $4.12M(+3.5%) |
| Jun 1998 | - | $1.04M(+11.9%) | $3.98M(+6.5%) |
| Mar 1998 | - | $932.00K(-6.8%) | $3.73M(+3.7%) |
| Dec 1997 | $3.59M(+13.5%) | $1.00M(0.0%) | $3.60M(+9.1%) |
| Sep 1997 | - | $1.00M(+25.0%) | $3.30M(+6.5%) |
| Jun 1997 | - | $800.00K(0.0%) | $3.10M(-3.1%) |
| Mar 1997 | - | $800.00K(+14.3%) | $3.20M(0.0%) |
| Dec 1996 | $3.16M(-14.8%) | $700.00K(-12.5%) | $3.20M(-8.6%) |
| Sep 1996 | - | $800.00K(-11.1%) | $3.50M(-5.4%) |
| Jun 1996 | - | $900.00K(+12.5%) | $3.70M(+5.7%) |
| Mar 1996 | - | $800.00K(-20.0%) | $3.50M(-5.4%) |
| Dec 1995 | $3.71M(+6.5%) | $1.00M(0.0%) | $3.70M(0.0%) |
| Sep 1995 | - | $1.00M(+42.9%) | $3.70M(+8.8%) |
| Jun 1995 | - | $700.00K(-30.0%) | $3.40M(-5.6%) |
| Mar 1995 | - | $1.00M(0.0%) | $3.60M(+2.9%) |
| Dec 1994 | $3.48M(-10.6%) | $1.00M(+42.9%) | $3.50M(-2.8%) |
| Sep 1994 | - | $700.00K(-22.2%) | $3.60M(-5.3%) |
| Jun 1994 | - | $900.00K(0.0%) | $3.80M(-5.0%) |
| Mar 1994 | - | $900.00K(-18.2%) | $4.00M(+2.6%) |
| Dec 1993 | $3.90M(+40.5%) | $1.10M(+22.2%) | $3.90M(+11.4%) |
| Sep 1993 | - | $900.00K(-18.2%) | $3.50M(+6.1%) |
| Jun 1993 | - | $1.10M(+37.5%) | $3.30M(+10.0%) |
| Mar 1993 | - | $800.00K(+14.3%) | $3.00M(+7.1%) |
| Dec 1992 | $2.77M(+51.8%) | $700.00K(0.0%) | $2.80M(+33.3%) |
| Sep 1992 | - | $700.00K(-12.5%) | $2.10M(+50.0%) |
| Jun 1992 | - | $800.00K(+33.3%) | $1.40M(+133.3%) |
| Mar 1992 | - | $600.00K | $600.00K |
| Dec 1991 | $1.83M | - | - |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual depreciation & amortization?
- What is the all time high annual D&A for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual D&A year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly D&A year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM depreciation & amortization?
- What is the all time high TTM D&A for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM D&A year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual depreciation & amortization?
The current annual D&A of VRTX is $207.20M
What is the all time high annual D&A for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual depreciation & amortization is $207.20M
What is Vertex Pharmaceuticals Incorporated annual D&A year-on-year change?
Over the past year, VRTX annual depreciation & amortization has changed by +$37.70M (+22.24%)
What is Vertex Pharmaceuticals Incorporated quarterly depreciation & amortization?
The current quarterly D&A of VRTX is $51.70M
What is the all time high quarterly D&A for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly depreciation & amortization is $54.00M
What is Vertex Pharmaceuticals Incorporated quarterly D&A year-on-year change?
Over the past year, VRTX quarterly depreciation & amortization has changed by -$2.30M (-4.26%)
What is Vertex Pharmaceuticals Incorporated TTM depreciation & amortization?
The current TTM D&A of VRTX is $199.80M
What is the all time high TTM D&A for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM depreciation & amortization is $207.90M
What is Vertex Pharmaceuticals Incorporated TTM D&A year-on-year change?
Over the past year, VRTX TTM depreciation & amortization has changed by +$3.00M (+1.52%)